Skip to main
UHS

UHS Stock Forecast & Price Target

UHS Analyst Ratings

Based on 10 analyst ratings
Buy
Strong Buy 30%
Buy 0%
Hold 70%
Sell 0%
Strong Sell 0%

Bulls say

Universal Health Services is a company that offers healthcare services through its behavioral health centers, acute care hospitals, and related outpatient facilities. The company has a strong presence in the US market, with key operations in Nevada, Texas, and California. Despite facing some headwinds from policy dynamics and execution risks, the company's highly profitable behavioral health segment and moderate growth in acute care services are expected to drive 5% adjusted EBITDA growth by 2027. This, combined with potential upside from improving behavioral volume trends and ongoing new-asset ramp-up, justifies our positive outlook on the stock, as reflected in our target price of $190.

Bears say

Universal Health Services is facing several challenges that will likely have a negative impact on its stock price. These include volume and margin headwinds, softness in core growth, and skepticism about the company's ability to overcome these challenges in the near future. Additionally, the company's operations are heavily concentrated in a few states, primarily in the US, leaving it vulnerable to regional economic and regulatory changes. Its performance is also heavily reliant on the performance of its behavioral health centers, which may face pressure from tightening state budgets and a tightening supply of clinical labor. Finally, investor concerns about diversity and inclusion, as well as potential environmental issues, may also weigh on the company's stock price in the future.

UHS has been analyzed by 10 analysts, with a consensus rating of Buy. 30% of analysts recommend a Strong Buy, 0% recommend Buy, 70% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Universal Health Services and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Universal Health Services (UHS) Forecast

Analysts have given UHS a Buy based on their latest research and market trends.

According to 10 analysts, UHS has a Buy consensus rating as of Aug 30, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $195.40, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $195.40, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Universal Health Services (UHS)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.